HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
HOME
HK STOCK
Announcement
ESSEX BIO-TECH (01061) spent 45,000 Hong Kong dollars to repurchase 20,000 shares on September 17th.
17/09/2024
GMT Eight
ESSEX BIO-TECH (01061) announced on September 17, 2024 that it spent HKD 45,000 to repurchase 20,000 shares.
SSY Group (02005) spent approximately HK$1.6282 million to repurchase 426,000 shares on September 17th.
SSY Group (02005) spent approximately HK$1.6282 million to repurchase 426,000 shares on September 17th.
RECOMMEND
SHUANG YUN HLDG(01706): The liquidator is continuing to work on handling the affairs of the subsidiary in the liquidation process.
55 min ago
H&H INTL HLDG (01112) achieved a total revenue of 9.648 billion yuan in the first three quarters, a decrease of 6.1% year-on-year.
1 h ago
Reduced-weight version of semaglutide launched in Chinese market! Novo Nordisk A/S Sponsored ADR Class B(NVO.US) unlocks new growth engine.
1 h ago
©️2013 - 2024 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com